-

New Medical Study Reports Reduced Depression and Anxiety Symptoms With Low Doses of CBD

Human Observational Study, Led by Realm of Caring Cannabis Research Group, Backs Findings from Published Animal Studies

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Realm of Caring (RoC), a nonprofit dedicated to cannabinoid research, has published its latest paper in the medical journal Frontiers in Psychiatry, examining the benefits of medicinal cannabis products for individuals with anxiety and depression. The longitudinal study, using data gathered from RoC’s Observational Research Registry (ORR), showed that individuals who initiated use of artisanal cannabidiol (CBD) products or continued use of CBD products at follow-up endorsed significant reductions in both anxiety and depression, improved sleep, and less pain compared with those not using CBD.

“The biggest misconception this study addresses is that CBD doses need to be between 400-600 mg before positive psychiatric effects can be achieved,” said Dr. Nicolas Schlienz, Research Director for Realm of Caring. “We observed positive effects in people taking an average of only about 60 mg per day, 1/10th of that dose.”

Schlienz conceptualized and co-authored the study alongside RoC’s President, Heather Jackson; Dr. Marcel Bonn-Miller, Vice President, Human and Animal Research at Canopy Growth Corporation; Dr. Ryan Vandrey, Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine; Erin Martin, Predoctoral Fellow at the Medical University of South Carolina; and Dr. Justin Strickland, Instructor at Johns Hopkins University.

Researchers sourced data from an online web survey conducted over a four-year period (2016-2020) focusing on participants’ self-reported anxiety and depression symptoms, and the need for an assessment on non-pharmaceutical CBD products widely available to consumers. For information on joining RoC’s ongoing research, visit www.realmofcaring.org.

About Realm of Caring

Through research and education, Realm of Caring (RoC) is facilitating the mainstream acceptance of cannabinoid-based therapies and building an empowered community. RoC is committed to research into novel healthcare options to improve quality of life. The organization leverages a deep bench of experience and leads with compassion to provide trusted resources, create support and build community for all who seek it. The 501(c)(3) high-impact independent public charitable organization has served tens of thousands of families and healthcare professionals since its inception in 2013.

Contacts

Lindsey Clarke
Grasslands: A Journalism-Minded Agency
lindsey@mygrasslands.com
970.690.8150

Realm of Caring


Release Versions

Contacts

Lindsey Clarke
Grasslands: A Journalism-Minded Agency
lindsey@mygrasslands.com
970.690.8150

More News From Realm of Caring

Research Nonprofit Launches World’s First Info Line for Psychedelic Education

DENVER--(BUSINESS WIRE)--Unlimited Sciences, Colorado’s leading psychedelic research nonprofit, debuts the first-of-its-kind Psychedelic Info Line, providing data-driven education and informed resources for individuals considering exploring psychedelics. With the primary goal of improving outcomes and reducing harm by offering comprehensive information on natural psychedelics, the Psychedelic Info Line navigators share knowledge from an extensive research library of peer-reviewed studies with d...

Nonprofits Team Up in the Battle Against Epilepsy in Children

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Beginning in January 2024, natural medicine research nonprofits Realm of Caring, Unlimited Sciences and Lily’s Lighthouse will collaborate to collect data for an observational study on the efficacy of functional mushrooms in treating epilepsy. Lily’s Lighthouse was founded in 2021 by Sarah-Kate Boylan, a mother seeking relief for her child, Lily, who was suffering from chronic seizures. After seven years of ineffective treatment, Sarah-Kate found prelim...

World's Largest Study on Naturalistic Psilocybin Use From Unlimited Sciences Reveals Lasting Therapeutic Benefits

DENVER--(BUSINESS WIRE)--Colorado-based psychedelic research nonprofit Unlimited Sciences recently published findings from an observational psilocybin (commonly known as ‘magic mushrooms’) study on the health effects of psilocybin use. The study, which represents the world’s largest longitudinal dataset on naturalistic psilocybin use to date, is published in Frontiers in Psychiatry and indicates broad therapeutic potential of a single dose of psilocybin to produce lasting improvements in mental...
Back to Newsroom